Stock Screener App

Gratuito -

Installare

79.29

2.04% -1.65

after-market

Dopo l'orario di chiusura: 78.88 -0.41 -0.52%

Disc Medicine Inc (IRON)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario

Disc Medicine Inc Borsa (IRON) Ultime notizie

Will Disc Medicine Inc. stock deliver strong dividend growthWeekly Trend Recap & Detailed Earnings Play Strategies - ulpravda.ru

How institutional buying supports Disc Medicine Inc. stockJuly 2025 Technicals & Technical Entry and Exit Tips - ulpravda.ru

How supply chain issues affect Disc Medicine Inc. stockWeekly Trading Summary & Intraday High Probability Setup Alerts - ulpravda.ru

Aug Selloffs: Why Disc Medicine Inc. stock is favored by top institutionsJuly 2025 Opening Moves & Growth Oriented Trade Recommendations - ulpravda.ru

Disc Medicine to Present at the 44th Annual J.P. Morgan Healthcare Conference - The Manila Times

Why Disc Medicine Inc. stock is seen as undervalued2026 world cup usa national team round of 16 young talents transition play winner prediction tactical review - ulpravda.ru

Disc Medicine, Inc. (IRON) Stock Analysis: Strong Buy Ratings and a Promising 54.73% Potential Upside - DirectorsTalk Interviews

Disc Medicine (NASDAQ:IRON) Insider Sells $511,485.00 in Stock - MarketBeat

Aug Catalysts: Will Disc Medicine Inc stock deliver strong dividend growth2025 Retail Activity & Safe Entry Momentum Tips - moha.gov.vn

Disc Medicine: RALLY-MF Data Validates Pipeline Optionality (NASDAQ:IRON) - Seeking Alpha

Disc Medicine (IRON) stock today: year-end rally keeps January FDA decision in focus - TechStock²

Precision Trading with Disc Medicine Inc. (IRON) Risk Zones - Stock Traders Daily

Disc Medicine, Inc. (IRON) Stock Analysis: Poised for 55% Upside Potential Amid Robust Analyst Confidence - DirectorsTalk Interviews

Disc Medicine Earnings Notes - Trefis

Analysts Conflicted on These Healthcare Names: Moderna (MRNA), Disc Medicine (IRON) and Sagimet Biosciences, Inc. Class A (SGMT) - The Globe and Mail

Analysts Offer Insights on Healthcare Companies: Cytokinetics (CYTK), Moderna (MRNA) and Disc Medicine (IRON) - The Globe and Mail

Analysts Have Conflicting Sentiments on These Healthcare Companies: AbbVie (ABBV), Disc Medicine (IRON) and BioMarin Pharmaceutical (BMRN) - The Globe and Mail

Disc Shares Slip Amid Report FDA’s Prasad is Skeptical of Bitopertin’s Efficacy - BioSpace

Avoiding Lag: Real-Time Signals in (IRON) Movement - news.stocktradersdaily.com

Breakouts Watch: Is Disc Medicine Inc. stock attractive for hedge fundsRisk Management & Free Growth Oriented Trading Recommendations - Улправда

Disc Medicine (NASDAQ: IRON) Stock Drops on FDA Voucher Speculation: Latest News, Analyst Forecasts, and What Investors Watch Next - ts2.tech

Breakout Watch: Can Disc Medicine Inc. stock deliver surprise earnings beatRisk Management & Technical Confirmation Trade Alerts - Улправда

Disc Medicine, Inc. (NASDAQ:IRON) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat

Can Disc Medicine Inc. stock deliver consistent earnings growthJuly 2025 Levels & Risk Controlled Swing Trade Alerts - Улправда

Stifel reaffirms Buy rating on Disc Medicine stock amid FDA review speculation - Investing.com Canada

Jefferies reiterates Buy rating on Disc Medicine stock amid FDA concerns - Investing.com Canada

Disc Medicine Stock Slides After FDA Fast-Track Approval Doubts Surface — Wall Street Calls It An ‘Overreaction’ - Asianet Newsable

Disc Medicine (IRON) Gains Confidence Despite Timeline Concerns - GuruFocus

Disc Medicine stock rating reiterated at Outperform by BMO amid FDA review - Investing.com

Disc Medicine (IRON) Maintains Positive Outlook Amid CNPV Skepti - GuruFocus

Disc Medicine drops on report of FDA skepticism over rare blood disorder drug - TradingView — Track All Markets

Disc Medicine (NASDAQ: IRON) Stock Tumbles on Insider-Selling Headlines as Bitopertin FDA Decision Nears — News, Analyst Forecasts, and What to Watch (Dec. 19, 2025) - ts2.tech

Disc Medicine Enters Oversold Territory (IRON) - Nasdaq

Disc Medicine (IRON) Shares Decline Over 14% - GuruFocus

FDA Fast-Track Review Challenges Impact Disc Medicine's (IRON) B - GuruFocus

Disc Medicine (NASDAQ:IRON) Shares Down 9% After Insider Selling - MarketBeat

Is Disc Medicine Inc. stock a buy before product launchesRate Hike & Expert Approved Momentum Trade Ideas - DonanımHaber

Aug Movers: Why Disc Medicine Inc stock is seen as undervalued2025 Earnings Impact & Capital Efficient Trading Techniques - moha.gov.vn

Downgrade Watch: Can Disc Medicine Inc. stock deliver surprise earnings beatJuly 2025 Recap & Daily Profit Focused Screening - Улправда

Disc Medicine (NASDAQ:IRON) Director Sells $68,968.38 in Stock - MarketBeat

symbol__ Stock Quote Price and Forecast - CNN

Short Covering: How analysts rate Disc Medicine Inc. stock todayFed Meeting & Weekly Setup with ROI Potential - Улправда

Hedge Fund Moves: Is Disc Medicine Inc. stock recession proofProduct Launch & Entry Point Confirmation Signals - Улправда

Is Disc Medicine Inc. stock attractive for hedge fundsChart Signals & Precise Swing Trade Entry Alerts - Bollywood Helpline

Disc Medicine Insider Sold Shares Worth $16,858,639, According to a Recent SEC Filing - marketscreener.com

Disc Medicine Insider Sold Shares Worth $1,194,372, According to a Recent SEC Filing - marketscreener.com

Kevin Bitterman Sells 62,693 Shares of Disc Medicine (NASDAQ:IRON) Stock - MarketBeat

Disc Medicine (NASDAQ:IRON) Insider William Jacob Savage Sells 13,093 Shares - MarketBeat

Insider Sell: William Savage Sells 13,093 Shares of Disc Medicine Inc (IRON) - GuruFocus

IRON Receives Updated Overweight Rating and Raised Price Target from Wells Fargo | IRON Stock News - GuruFocus

Disc Medicine (NASDAQ:IRON) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says - MarketBeat

John Quisel Sells 40,000 Shares of Disc Medicine (NASDAQ:IRON) Stock - MarketBeat

Disc Medicine Insider Sold Shares Worth $3,721,931, According to a Recent SEC Filing - marketscreener.com

Frazier Life Sciences Management L.P. Has $87.64 Million Holdings in Disc Medicine, Inc. $IRON - MarketBeat

This is why Disc Medicine, Inc. (IRON) is a buy on Wall Street - MSN

All You Need to Know About Disc Medicine, Inc. (IRON) Rating Upgrade to Buy - MSN

Eventide Asset Management LLC Buys 126,212 Shares of Disc Medicine, Inc. $IRON - MarketBeat

Disc Medicine, Inc. $IRON Position Lowered by Bain Capital Life Sciences Investors LLC - MarketBeat

Has Disc Medicine’s 2025 Surge Already Gone Too Far After Pipeline Progress Fuels Rally? - Yahoo Finance

GMAB

$33.63

0.80%

RVMD

$107.39

4.56%

INCY

$105.92

4.21%

BNTX

$98.85

1.23%

ONC

$320.37

4.04%

INSM

$170.27

3.26%

Apri su Yahoo | Apri su Google | Aperto in Finviz | Apri in MarketWatch | Aperto a EDGAR | Aperto su Reuters